Peh-Med — Israeli Startup

About

Peh-Med develops IntelliDrug, a platform thatprovides analternative to traditional drug deliverymethods like injections and pills. The IntelliDrug enables users to accurately define every dose, start and stop drug delivery precisely, and adjust the dose to variations in health status. The IntelliDrug device's automatic operation overcomes the problem generated when patients forget to take their medication. Moreover, it can be easily adjusted to weight, age, sex, treatment characteristics, way of living, etc.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary product developed by Peh-Med?

Peh-Med develops IntelliDrug, a platform designed for intraoral drug delivery as an alternative to traditional methods like injections and pills.

When was Peh-Med founded?

Peh-Med was founded in January 2007.

What is the current status of Peh-Med?

Peh-Med is currently inactive, with its status marked as 'Non Active' as of November 2016.

Where is Peh-Med headquartered?

Peh-Med is headquartered in Kiryat Ono, Israel, at 44 Kaplan St., 55293.

In which geographic market did Peh-Med have a presence?

Peh-Med had a presence in Germany.

How many employees did Peh-Med have?

Peh-Med had 6 employees.

What is Peh-Med's primary sector classification?

Peh-Med's primary sector classification is Health Tech & Life Sciences.

What is the core functionality of the IntelliDrug device?

The IntelliDrug device allows users to precisely define, start, and stop drug delivery, adjust doses based on health status, and operates automatically to address medication adherence issues.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics

Target customers

Healthcare & Life SciencesHealthcarePatients

Peh-Med — Full Company Profile (machine-readable)

Intraoral Drug Delivery

About

Facts

Name	Peh-Med
Slug	peh-med
Type	Israeli Startup
Founded	2007
HQ city	Kiryat Ono
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object], [object Object], [object Object]
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Pre-Funding
Public stage	Pre-Funding
Total raised (USD)	0
Israeli Companies Registrar	514318948

Team (1)

Name	Role	LinkedIn
Ben Beiski

Intelligence Q&A

What is the primary product developed by Peh-Med?

Peh-Med develops IntelliDrug, a platform designed for intraoral drug delivery as an alternative to traditional methods like injections and pills.

When was Peh-Med founded?

Peh-Med was founded in January 2007.

What is the current status of Peh-Med?

Peh-Med is currently inactive, with its status marked as 'Non Active' as of November 2016.

Where is Peh-Med headquartered?

Peh-Med is headquartered in Kiryat Ono, Israel, at 44 Kaplan St., 55293.

In which geographic market did Peh-Med have a presence?

Peh-Med had a presence in Germany.

How many employees did Peh-Med have?

Peh-Med had 6 employees.

What is Peh-Med's primary sector classification?

Peh-Med's primary sector classification is Health Tech & Life Sciences.

What is the core functionality of the IntelliDrug device?

The IntelliDrug device allows users to precisely define, start, and stop drug delivery, adjust doses based on health status, and operates automatically to address medication adherence issues.

About

Company Intelligence Q&A

Sectors & technology

Tags

Generate Slim Page